Search Results 1801-1810 of 173443 for Developmental disorder

  1. John A. Lucas, Ph.D. - Mayo Clinic Faculty Profiles

    He is also interested in the cognitive effects of surgical interventions for movement disorders, such as Parkinson's disease and essential tremor. Focus areas.

  2. Matthew J. Koster, M.D. - Mayo Clinic Faculty Profiles

    Through understanding the trends in incidence, changes in diagnostic modalities, risk factors associated with disease development, frequency of disease- ...

  3. Naphazoline (ophthalmic route) - Side effects & dosage - Mayo Clinic

    Mayo Clinic School of Continuous Professional Development ... Search for a disease or condition . Type 3 or ... Heart disease or; High blood pressure or ...

  4. Hydralazine (injection route) - Side effects & uses - Mayo Clinic

    Mayo Clinic School of Continuous Professional Development ... Search for a disease or condition . Type 3 or ... Blood disease or; Heart attack, history of ...

  5. Joel M. Reid, Ph.D. - Mayo Clinic Faculty Profiles

    Reid's research is conducted with oncology drugs in the late stages of preclinical development or early stages of clinical development; these phases of ...

  6. Polycystic kidney disease - Doctors and departments - Mayo Clinic

    Lab-based research at Mayo Clinic has focused on: Explaining how mutations in the polycystic kidney disease genes lead to cyst development. Preclinical studies ...

  7. MEDIA ADVISORY: Mayo Clinic Center for Regenerative Medicine and Rochester Area Economic Development, Inc. to Host Open House for Advanced Product Incubator

    MEDIA ADVISORY: Mayo Clinic Center for Regenerative Medicine and Rochester Area Economic Development, Inc. ... diseases. Reporters will have a chance to tour ...

  8. Prader-Willi syndrome - Mayo Clinic

    In children, they improve muscle tone and so improve motor development. They have an improvement in bone mineral density accrual and they also have improvement ...

  9. Major advance in use of CAR-T cell therapy to treat solid tumors - Mayo Clinic

    A cross-disciplinary effort at Mayo Clinic has led to a breakthrough development in the use of CAR-T cell therapy to treat solid tumors ... Search for a disease ...

  10. To Compare the Effects of Immediate-release Tacrolimus and Astagraf XL on Donor-Specific Antibody (DSA) Formation and the Development of Immune Activation (IA) in de Novo Kidney Transplant Recipients - Mayo Clinic

    To Compare the Effects of Immediate-release Tacrolimus and Astagraf XL on Donor-Specific Antibody (DSA) Formation and the Development of Immune Activation (IA) ...